Antibody Europe Post-Event Report
Welcome to the post-event wrap-up of the largest Antibody Engineering & Therapeutics Europe event to date. On 6 – 8 June 2023 350+ attendees from across the antibody community gathered in Amsterdam to discuss the latest cutting-edge research and...
Introduction
Single B Cell Based Technology for Monoclonal Antibody Discovery
A Recipe for Data-driven Therapeutic Discovery: Advances, Ingredients, and Applications
Maximizing Antibody Diversity – Mouse, Rat and Rabbit on the Beacon® Optofluidic Instrument
The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking Through Critical Synthesis Bottlenecks
Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, and Machine Learning
Get the Full Scoop on Your ADC from Microliters
Use of Multiple Biophysical Technologies in Parallel for a Streamlined Biologics Selection Process
First-in-Human Studies of a Novel VHH-Fc Antibody Construct in Healthy Subjects and Patients Hospitalized for Mild to Moderate
COVID-19
A Synthetic, Yeast-Based Platform for Integrated Discovery and Production of Heavy Chain Antibodies
OmniAb® Platform for High-Throughput Gene Cloning, Expression, Purification and Characterization
Diversity of Fc Effector Function in Antibody-Based Therapeutics
In situ Imaging of IgG3-mediated Complement Activation Using Cryo-electron Tomography Reveals Novel Structural Insights into Immune Defense
How Antibodies and Complement Orchestrate Protective Immune Responses Against Bacteria
Current and Next Generation ADCs: Successes and Failures
Impact of Affinity on the Activity of Immunomodulatory Antibodies
Combination Strategies to Boost T Cell Bispecific Antibodies Activities